Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and...
27 insider purchases on record · latest filing 2026-08-20.
Insiders have also filed 77 sale transactions at SENS.